Citations for
1MYL2
Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
Frau M, Ladu S, Calvisi DF, Simile MM, Bonelli P, Daino L, Tomasi ML, Seddaiu MA, Feo F, Pascale RM.
J Hepatol 55(1):111-9. Epub 2010 Dec 7. 2011
2MYL2
Slow cardiac myosin regulatory light chain 2 (MYL2) was down-expressed in chronic heart failure patients.
Li Y, Wu G, Tang Q, Huang C, Jiang H, Shi L, Tu X, Huang J, Zhu X, Wang H.
Clin Cardiol 34(1):30-4. doi: 10.1002/clc.20832. Epub 2010 Dec 10. 2011
3CMH10, MYL2
Cardiomyopathy-linked myosin regulatory light chain mutations disrupt myosin strain-dependent biochemistry.
Greenberg MJ, Kazmierczak K, Szczesna-Cordary D, Moore JR.
Proc Natl Acad Sci U S A 107(40):17403-8. Epub 2010 Sep 20. 2010
4MYL2
Malignant familial hypertrophic cardiomyopathy D166V mutation in the ventricular myosin regulatory light chain causes profound effects in skinned and intact papillary muscle fibers from transgenic mice.
Kerrick WG, Kazmierczak K, Xu Y, Wang Y, Szczesna-Cordary D.
FASEB J 23(3):855-65. Epub 2008 Nov 5. 2009
5ACTC1, CMH1, CMH11, CMH4, MYBPC3, MYH7, MYL2, MYL3, PRKAG2, TNNI3, TNNT2, TPM1
Shared genetic causes of cardiac hypertrophy in children and adults.
Morita H, Rehm HL, Menesses A, McDonough B, Roberts AE, Kucherlapati R, Towbin JA, Seidman JG, Seidman CE.
N Engl J Med 358(18):1899-908. Epub 2008 Apr 9. 2008
6MYL2
Cardiac myosin light chain-2: a novel essential component of thick-myofilament assembly and contractility of the heart.
Rottbauer W, Wessels G, Dahme T, Just S, Trano N, Hassel D, Burns CG, Katus HA, Fishman MC.
Circ Res 99(3):323-31. Epub 2006 Jun 29. 2006
7CMH10, MYL2
Familial hypertrophic cardiomyopathy-linked alterations in Ca2+ binding of human cardiac myosin regulatory light chain affect cardiac muscle contraction.
Szczesna-Cordary D, Guzman G, Ng SS, Zhao J.
J Biol Chem 279(5):3535-42. Epub 2003 Nov 1. 2004
8MYL1, MYL2, MYL3, PITX2
Multiple transcriptional domains, with distinct left and right components, in the atrial chambers of the developing heart.
Franco D, Campione M, Kelly R, Zammit PS, Buckingham M, Lamers WH, Moorman AF.
Circ Res 87(11):984-91. 2000
9CMH8, CMH10, MYL2, MYL3
Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle.
Poetter K, et al.
Nat Genet 13 : 63-68. 1996
10MYL2
Localization of the gene coding for ventricular myosin regulatory light chain (MYL2) to human chromosome 12q23-q24.3.
Macera MJ, et al.
Genomics 13 : 829-831. 1992